Granules India Ltd share price was up by 0.69% from the previous closing price of ₹578.90. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals Industries ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13,799.10 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

We're going to get warm and cozy with the peasants as we build up a medieval city in this week's episode of Indie-licious.

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Ibuprofen, one of the most widely used nonsteroidal anti-inflammatory drugs, is a poor ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children. Jan 30, 2025 14:05 ...

Laboratory for Innovative Key Materials and Structures (LINK), CNRS-Saint-Gobain-NIMS, IRL 3629, 1-1 Namiki, Tsukuba 305-0044, Japan ...